Long-acting insulin degludec – and degludec combo drug – win FDA nodSeptember 26, 2015Lipid DisordersDiabetes
EASD: SGLT2 inhibitor empagliflozin cuts CV risk in patients with type 2 diabetesSeptember 18, 2015DiabetesLipid Disorders
Laparoscopic sleeve gastrectomy: Comorbidity benefits fade with timeAugust 5, 2015ObesityLipid Disorders
ADA: Thiazolidinediones, sulfonylureas best DPP-4s for metformin-based dual GLTJune 15, 2015DiabetesLipid Disorders
AACE: Saroglitazar found safe, effective for management of diabetic dyslipidemiaJune 10, 2015Lipid DisordersDiabetes
ELIXA trial: No cardiovascular risk with GLP-1 receptor agonist lixisenatideJune 9, 2015DiabetesLipid Disorders
OARSI: Chronic conditions complicate osteoarthritis treatment, complianceMay 29, 2015DiabetesLipid DisordersHypertensionObesity
Metabolic syndrome incidence may be stabilizingMay 19, 2015Lipid DisordersDiabetesObesityHypertension
